Some factors which could have contributed to these discrepancies are that the study included a higher number of patients with IBD and anemia and that due to small sample sizes, during the statistical analysis of the data, the researchers combined CD and UC patients together in order to report hepcidin levels (Mecklenburg et al., 2014). This evidence concerns the gene HAMP and anemia (phenotype).